WO2024209404 - RNA DELIVERY VEHICLE
National phase entry:
Publication Number
WO/2024/209404
Publication Date
10.10.2024
International Application No.
PCT/IB2024/053321
International Filing Date
05.04.2024
Title **
[English]
RNA DELIVERY VEHICLE
[French]
VÉHICULE D'ADMINISTRATION D'ARN
Applicants **
SEQIRUS INC.
Inventors
ROCKMAN, Steven
LAURIE, Karen Louise
MCMAHON, Meagan Kathleen
Priority Data
63/494,274
05.04.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2672 | |
| EPO | Filing, Examination, Granting | 17803 | |
| Japan | Filing, Examination, Granting | 2492 | |
| South Korea | Filing, Examination, Granting | 2704 | |
| USA | Filing, Examination, Granting | 5310 |
Total:
30,981
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure relates to an RNA delivery vehicle comprising lipid nanoparticles comprising the RNA therein, and a RNA-binding protein or peptide coated on the exterior surface of the lipid nanoparticle, and uses thereof.[French]
La présente invention concerne un véhicule d'administration d'ARN comprenant des nanoparticules lipidiques à l'intérieur desquelles l'ARN se trouve, et une protéine ou un peptide de liaison à l'ARN appliqué sur la surface extérieure de la nanoparticule lipidique, et ses utilisations.